Skip to main content
. Author manuscript; available in PMC: 2007 Mar 1.
Published in final edited form as: Am J Physiol Lung Cell Mol Physiol. 2005 Oct 7;290(3):L415–L425. doi: 10.1152/ajplung.00276.2005

Table 1.

Clinical characteristics of ARDS patients

Patient Age, yr Sex Diagnosis ARDS Days MV Days BAL Day Outcome
1 36 M CAP 9 10 3 Survival
2 55 F Pneumonia (HAP) 5 5 2 Survival
3 44 F Severe sepsis 10 10 2 Death
4 75 F Pneumonia (HAP) 14 20 7 Death
5 32 M Aspiration 5 15 5 Survival
6 49 M Pneumonia (HAP) 8 8 2 Survival
7 33 M Pneumonia (CAP) 11 12 10 Survival
8 33 F Pneumonia (HAP) 4 4 2 Survival
9 50 F Aspiration 21 24 8 Survival
10 48 M Hemorrhagic shock 2 6 1 Survival
11 29 F Pneumonia (CAP) 7 14 6 Survival
12 39 M Polysubstance overdose 2 6 1 Survival
13 43 M Necrotizing pancreatitis 4 4 3 Survival

ARDS days, number of days that patient met American-European Consensus Conference criteria for acute respiratory distress syndronic (ARDS) (PaO2/FiO2 < 200; bilateral pulmonary infiltrates on chest radiograph; presence of risk factor(s) for ARDS; no evidence of left atrial hypertension) starting at day 0 as first day that diagnostic criteria were met. MV days, total number of days that the patient required mechanical ventilation (MV). BAL day, day of ARDS on which bronchoalveolar lavage (BAL) was performed. Survival implies that the patient was alive at 30 days post-ARDS. M, male; F, female; CAP, community-acquired pneumonia; HAP, hospital acquired pneumonia.